Article Information
History
- December 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Gissel García1a,
- Josanne Soto1b,
- Lays Rodríguez1c,
- Maricela Nuez1d,
- Noraika Domínguez1d,
- Emilio F. Buchaca1c,
- Duniesky Martínez2,
- Rolando J. Gómez1b,
- Yohanka Ávila1c,
- Martha R. Carlin3 and
- Raúl J. Cano3,4,*
- 1aPathology Department, Clinical Hospital Hermanos Ameijeiras (HHA). Calle San Lázaro No 701, Esq.a Belascoaín, Centro Habana, La Habana, P.C. 10400, Cuba
- 1bClinical Laboratory Department, Clinical Hospital Hermanos Ameijeiras (HHA). Calle San Lázaro No 701, Esq.a Belascoaín, Centro Habana, La Habana, P.C. 10400, Cuba
- 1cInternal Medicine Department, Clinical Hospital Hermanos Ameijeiras (HHA). Calle San Lázaro No 701, Esq. a Belascoaín, Centro Habana, La Habana, P.C. 10400, Cuba
- 1dEndocrinology Department, Clinical Hospital Hermanos Ameijeiras (HHA). Calle San Lázaro No 701, Esq.a Belascoaín, Centro Habana, La Habana, P.C. 10400, Cuba
- 2Research and Development Department. Center for Genetic Engineering and Biotechnology of Sancti Spíritus (CIGBSS),. Circunvalante Norte S/N, Olivos 3, Apartado Postal 83, Sancti Spíritus, P.C 60200, Cuba
- 3The BioCollective, LLC, 5650 N. Washington St, Suite C9, Denver, Co 80216
- 4Biological Sciences Department, California Polytechnic State University, San Luis Obispo, CA 93407 USA
- ↵*Corresponding author and address: 1854 Castillo Court, San Luis Obispo, CA 93405 USA; Tel: +1 (805) 748-9717; E-mail: rcano{at}calpoly.edu
Posted December 07, 2022.
A Randomized Placebo Controlled Clinical Trial of a Metabolic Shifting Probiotic, Sugar Shift, for the Treatment of T2DM
